Suchergebnisse - "Lu, Tianzhu"

PubPharm (60)

41

Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma

enthalten in: Head & Neck | 2021

von Xu, H. | Lu, L. | Lu, T. | +11

42

Association of Neutrophil-to-Lymphocyte Ratio, Neutrophil Count, and VEGF on Metastasis in Patients with Nasopharyngeal Carcinoma

enthalten in: ResearchSquare.com | 2020

von Xingming, Y. | Lu, T. | Bai, W. | +4

43

Association of neutrophil-to-lymphocyte ratio, neutrophil count, and VEGF on metastasis in patients with nasopharyngeal carcinoma

enthalten in: ResearchSquare.com | 2020

von Ye, X. | Lu, T. | Bai, W. | +4

44

Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma

enthalten in: Cancer science | 2020

von Lu, T. | Guo, Q. | Lin, K. | +12

45

Diagnostic and prognostic performance of circulating levels of the Epstein-Barr virus microRNAs BART 7-3p and BART 13-3p in nasopharyngeal carcinoma

enthalten in: ResearchSquare.com | 2020

von Lu, T. | Guo, Q. | Lin, K. | +12

46

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma

enthalten in: Cancer medicine | 2020

von Zhou, H. | Lu, T. | Guo, Q. | +9

47

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy : A Single-Institution Experience

enthalten in: Cancer management and research | 2020

von Guo, Q. | Chen, M. | Xu, H. | +10

ErratumIn: Cancer Manag Res. 2020 Mar 31;12:2365-2366. - PMID 32308475

48

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma

enthalten in: OncoTargets and therapy | 2020

von Lu, T. | Chen, Y. | Li, J. | +8

49

Prognostic value of radiologic extranodal extension and its potential role in future N classification for nasopharyngeal carcinoma

enthalten in: Oral oncology | 2019

von Lu, T. | Hu, Y. | Xiao, Y. | +9

50

Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era

enthalten in: Head & neck | 2019

von Lu, T. | Xie, X. | Guo, Q. | +6